Login/Register
  • 中文
  • English

News

GlycoNex to Launch New Biosimilar Project in Q2 Targeting Psoriasis and Autoimmune Markets

GlycoNex announced yesterday that it will initiate its second biosimilar development program in Q2 2026, targeting Psoriasis and other immune-related diseases.

Read more
Feb 24, 2026
Anxo Pharmaceutical Transfers Five Drug Licenses to Synmosa for Upfront and Milestone Payments
Feb 24, 2026
Formosa Pharmaceuticals Partners with Arrotex to Enter Australia and New Zealand Ophthalmic Markets
Feb 23, 2026
2026: The "Showdown Year" for Taiwan’s Biotech as 10 Blockbuster Drugs Enter the Global Arena
Feb 23, 2026
Japan MHLW Approves PharmaEssentia’s High-Dose Ropeg Regimen
Feb 23, 2026
Oneness Biotech’s Bonvadis Receives Marketing Authorization in Colombia
Feb 23, 2026
Hanchor Bio’s HCB101 Granted U.S. FDA Orphan Drug Designation for Gastric Cancer
Feb 13, 2026
Institutional Investors Bullish on Global Life Sciences Outlook Driven by Three Core Engines
Feb 13, 2026
Foresee Pharmaceuticals Reports Dual Success: CAMCEVI Global Expansion and FP-001 Phase III Victory
Feb 13, 2026
XTALPI Delivers Multi-Million RMB Robotic AI Laboratory to South Korea’s JW Pharmaceutical

Most Watched

Recommended

BriteMED® 27
BriteMED Technology Inc.
2nd Operation
MING FONG TECHNOLOGY CO., LTD.
Stem Cell Medicine Development
Hualien Tzu Chi Medical Center

Industry Watch

Read more